Millions take it for asthma and allergies, but Singulair is under scrutiny. The popular drug, prescribed for decades, is linked to an array of psychiatric symptoms—from nightmares and depression to suicidal thoughts.
As regulators slap its packaging with warnings of neuropsychiatric issues and patients recount similar experiences, a question looms: How did a once-celebrated treatment become problematic for some? As families seek answers, scientists work to unravel how a medication meant to ease breathing could cloud the mind.
FDA and Global Health Warnings
The Medicines and Healthcare products Regulatory Agency (MHRA), a UK government agency, announced that more prominent warnings will be added to the information leaflet for the asthma drug montelukast, sold as Singulair....
↧